Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies - Almontashiri, Naif A. M.; Vilmundarson, Ragnar O.; Ghasemzadeh, Nima; Dandona, Sonny; Roberts, Robert; Quyyumi, Arshed A.; Chen, Hsiao-Huei; Stewart, Alexandre F. R. (PloS one, 2014)
Keywords: Anticholesteremic agents; Arteriosclerosis; Atherosclerosis; Biochemistry; Biological Specimen Banks; Biology and Life Sciences; Blood cholesterol; Canada; Cardiology; Cardiovascular disease; Case-Control Studies; Cholesterol; Coronary Angiography; Coronary artery; Coronary Artery Disease - blood; Coronary vessels; Diabetes; Drugs; Enzyme-linked immunosorbent assay; Female; Genetics; Genomics; Health risk assessment; Heart; Heart attack; Heart attacks; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Immunology; Kexin; Linear Models; Logistic Models; Low density lipoprotein; Low density lipoprotein receptors; Low density lipoproteins; Male; Medical imaging; Medicine; Middle Aged; Mutation; Myocardial infarction; Myocardial Infarction - blood; Myocardial Infarction - drug therapy; Proprotein Convertase 9; Proprotein convertases; Proprotein Convertases - blood; Receptor density; Retrospective Studies; Secretion; Serine Endopeptidases - blood; Stenosis; Studies; Subtilisin; Canada; Montreal Quebec Canada; Ottawa Ontario Canada